【レポートの概要（一部）】
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview
Orphan medicines legislation
Orphan medicines centralized procedure in US/EU
Product registration process for orphan drugs in Japan
Orphan drug designations and approvals
Annual cost of orphan drugs
R&D costs for orphan and non-orphan drugs
PART 06: Pipeline snapshot
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by product
Global biologic orphan drugs market
Global non-biologic orphan drugs market
PART 09: Geographical segmentation
Orphan drugs market in Americas
Orphan drugs market in EMEA
Orphan drugs market in APAC
PART 10: Market drivers
Shorter development timelines
Assistance from regulatory bodies
Incentives for developing orphan drugs
High return on investment
Exemption from pricing constraints
PART 11: Impact of drivers
PART 12: Market challenges
High cost of drug development
Decreased investment in marketing
Complications in conducting clinical trials
Unknown pathophysiology
Adverse policies of FDA
PART 13: Impact of drivers and challenges
PART 14: Market trends
Increased focus on biological drugs
Growing awareness of orphan drugs
Channel marketing strategy
Expansion of business
Entry into untapped market
PART 15: Vendor landscape
Competitive scenario
Major vendors 2014
Worldwide orphan drug sales revenue: Top 17 companies 2013
Top 10 orphan drugs in US 2014
Other prominent vendors
PART 16: Key vendor analysis
BMS
Celgene
Novartis
Pfizer
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: History of orphan medicines legislation
Exhibit 03: Incentives provided by US regulation
Exhibit 04: Incentives provided by Japanese regulation
Exhibit 05: Incentives provided by EU regulation
Exhibit 06: Incentives provided by Australian regulation
Exhibit 07: Incentives provided by South Korean regulation
Exhibit 08: Incentives provided by Singapore regulation
Exhibit 09: Orphan drug regulatory process in EU/US
Exhibit 10: Orphan drug registration process in Japan
Exhibit 11: Orphan drug development and regulatory challenges
Exhibit 12: Orphan drug designations and approvals in US 2000-2014
Exhibit 13: Number of novel orphan molecular entities launched in US 2004-2013
Exhibit 14: Novel orphan molecular entities launched in US 2013
Exhibit 15: Number of orphan drug designations and approvals in Japan 2000-2012
Exhibit 16: Number of orphan medicinal products launched in Europe 2002-2014
Exhibit 17: Top orphan drug designation indications in EU 2014
Exhibit 18: Approved and designated orphan pharmaceutical products in US, EU, Japan, and Australia
Exhibit 19: Cumulative orphan designations in US, EU, and Japan per year 2000-2013
Exhibit 20: Source: Technavio, 2015Orphan drug designations by therapy areas 2013
Exhibit 21: Average annual cost of orphan drugs per patient in US 2010-2014 ($)
Exhibit 22: Annual cost of several orphan drugs
Exhibit 23: Cost comparison of branded orphan drugs versus generic versions 2013 ($)
Exhibit 24: Orphan drug expenditure by therapeutic class 2007-2013
Exhibit 25: R&D cost for Phase III trial for orphan and non-orphan drugs 2013 and 2014 ($ billions)
Exhibit 26: The worldwide top late-stage and filed orphan drugs are given below:
Exhibit 27: Global orphan drugs market ($ billions)
Exhibit 28: Five forces analysis
Exhibit 29: Global orphan drugs market by product
Exhibit 30: Global orphan drugs market by product 2014
Exhibit 31: Global biologic orphan drugs market 2014-2019 ($ billions)
Exhibit 32: Global non-biologic orphan drugs market 2014-2019 ($ billions)
Exhibit 33: Global orphan drugs market by geographical segmentation 2014
Exhibit 34: Orphan drugs market in Americas 2014-2019 ($ billions)
Exhibit 35: Orphan drugs market in EMEA 2014-2019 ($ billions)
Exhibit 36: Orphan drugs market in APAC 2014-2019 ($ billions)
Exhibit 37: )Global orphan drugs market by geographical segmentation 2014-2019 ($ billions)
Exhibit 38: Drivers of global orphan drugs market
Exhibit 39: FDA filed to approved time: orphan versus non-orphan drugs (median time months)
Exhibit 40: Phase III trial length orphan versus non-orphan drugs (median length years)
Exhibit 41: Impact of drivers
Exhibit 42: Challenges in global orphan drugs market
Exhibit 43: Impact of key drivers and challenges
Exhibit 44: Trends in global orphan drugs market
Exhibit 45: BMS: Key takeaways
Exhibit 46: Celgene: Global year-over-year growth and revenue of Vidaza 2012-2014 ($ millions)
Exhibit 47: Celgene: Global year-over-year growth and revenue of Revlimid 2012-2014 ($ billions)
Exhibit 48: Celgene: Key takeaways
Exhibit 49: Novartis: Key takeaways
Exhibit 50: Pfizer: Year-on-year growth rate and revenue of Inlyta 2012-2014 ($ millions)
Exhibit 51: Pfizer: Key takeaways
Exhibit 52: Global year-over-year growth and revenue of Rituxan/MabThera 2010-2014 ($ billions)
Exhibit 53: Avastin: Global revenue and year-over-year growth 2010-2014 ($ billions)
Exhibit 54: Roche: Key takeaways
Exhibit 55: Worldwide orphan drug sales 2007-2013 ($ billions)
Exhibit 56: BMS: Business segmentation by revenue 2014
Exhibit 57: BMS: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 58: BMS: Geographical segmentation by revenue 2014
Exhibit 59: Celgene: Product segmentation by revenue 2014
Exhibit 60: Celgene: Product segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 61: Celgene: Geographical segmentation by revenue 2014
Exhibit 62: Roche: Business segmentation by revenue 2014
Exhibit 63: Roche: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 64: Roche: Geographical segmentation by revenue 2014
Exhibit 65: Novartis: Business segmentation by revenue 2014
Exhibit 66: Novartis: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 67: Novartis: Geographical segmentation by revenue 2014
Exhibit 68: Pfizer: Business segmentation by revenue 2014
Exhibit 69: Pfizer: Business segmentation by revenue 2014 (%)
Exhibit 70: Pfizer: Geographical segmentation by revenue 2014
【レポート販売概要】
■ タイトル：希少疾病用医薬品（OD）の世界市場2015-2019■ 英文：Orphan Drugs Market 2015-2019
■ 発行日：2015年11月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR7493
■ 調査対象地域：グローバル
- レンタカーの世界市場予測・分析2020-2024Global Car Rental Market: About this market Technavio’s car rental market analysis considers sales from airport transport, local transport, outstation transport, and other transport. Our study also finds the sales of car rental in APAC, Europe, MEA, North America, and South America. In 2019, the airport transport segment had a significant market share, and this trend is expected to continue over t …
- 世界の神経修復・神経再生市場：異種移植片、神経調節、手術などThe nerve repair and regeneration market was worth $4.1 billion in 2012 and is expected to grow at a CAGR of 11.5% in the next five years, primarily due to technological advancements and favorable reimbursement policies. The market is expected to witness a high growth in nerve grafting and neuromodulation segments, as they offer effective solutions for peripheral nerve repair and chronic pain, inc …
- Burkitt Lymphoma：グローバル臨床試験レビューH2, 2013Burkitt Lymphoma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H2, 2013" provides data on the Burkitt Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Burkitt Lymphoma. It includes an overview of the trial numbers and their recruitment statu …
- 産業制御および工場自動化の世界市場：SCADA、MES、DCS、PLC、電動駆動装置、保護継電器、センサThe increasing adoption of automation by factories in the US, China, and Germany has propelled the growth of the global industrial controls and factory automation market, which has resulted in a projected CAGR of more than 7% for the market. This automation market is implemented by all process and discrete industries. In terms of geographical revenue contribution, the APAC region occupied the bigg …
- ネットワーク・フォレンジックス（鑑識）の世界市場予測（～2021）The network forensics market size is expected to grow from USD 1.25 Billion in 2016 to USD 2.69 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 16.6% during the forecast period. The major growth drivers of the market include increased need to secure networks from advanced attacks, such as ransomware, Distributed Denial of Service (DDoS), and Advanced Persistent Threats (APTs); increase …
- メキシコ/インドネシア/ナイジェリア/トルコの防衛市場：市場魅力度、機会（～2019）Synopsis This report provides a detailed analysis of the current industry size and growth expectations during 2015–19, including highlights of the key growth stimulators. It also benchmarks the industry against key global markets and provides detailed understanding of emerging opportunities in specific areas. Summary SDI's "The MINT Defense Industry - Market Attractiveness and Emerging Opportuniti …
- ストレージ仮想化の世界市場2015-2019The increase in implementation of virtualization solutions has led to a rapid development of server virtualization solutions. It increases the productivity of servers and the network as a whole. Technavios market research analysts predict the global storage virtualization market to grow at a CAGR of more than 24% from 2015 to 2019. There need for centralization of all processes in the network and …
- 空港小売サーベイおよびラグジュアリー動向Summary “Airport Retail Survey and Luxury Trends 2015-2016” is a new report by Conlumino that globally analyzes prevailing trends in airport retailing and explores how travelers use airport retailing with specific insight on luxury brands, and how the dynamics are set to change in 2015-2016. This report highlights the key factors influencing customer opinion and purchasing patterns, and identifies …
- 偽装テクノロジの世界市場予測（～2021年）The rise in Advanced Persistent Threats (APTs) and zero-day attacks trends is expected to drive the deception technology marketThe deception technology market size is estimated to grow from USD 1.04 billion in 2016 to USD 2.09 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 15.1%. The deception technology market is driven by factors such as rise in Advanced Persistent Threats (APTs) an …
- 暗視装置（ナイトビジョンデバイス）の世界市場2016-2020About Night Vision Devices Night vision devices collect the existing ambient light, including moonlight, starlight, or IR light, through the front lens. This light, which is made of photons, is converted to electrons by passing through a photocathode tube. The electrons are then amplified through a chemical and electrical process and thrown against a phosphorous screen that converts the electrons …
- 世界のジャッキアップリグ市場2015The Global Jackup Rig Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Jackup Rig industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Jackup Rig market analysis is provided for the international markets including development trends, competitive lands …
- 世界の衣類産業におけるRFID半導体市場動向（2012-2016）TechNavio's analysts forecast the Global Radio Frequency Identification (RFID) Semiconductor market in the Apparel industry to grow at a CAGR of 19.8 percent over the period 2012-2016. Mandates made by retail giants that require suppliers to use RFID is one of the key factors contributing to this market growth. The Global RFID Semiconductor market in the Apparel industry has also been witnessing i …
- マイクロ熱電併給（マイクロCHP）の世界市場：エンジン、燃料電池The global micro CHP market is projected to grow at a CAGR of 14.2% during the forecast period, to reach USD 4.44 Billion by 2020. This growth is attributed to high energy efficiency, which is achieved by converting primary energy to heat and electricity at the end-user level. Micro CHP units have the potential to reduce CO2 emissions that reduces energy consumption as compared to the conventional …
- 自動車用パワートレイン試験サービスの世界市場2019-2023About this market In developing countries, the local implementations of emissions standards are derived from the three major legislative standards of EPA, EURO and Japanese standards. These emission control regulations force automotive manufacturers to improve the efficiency of the engine using different methods. Stringent emission control norms will be the major drivers for the market. European O …
- 月経カップの世界市場2016-2020About Menstrual Cup A menstrual cup is a form of menstrual protection that forms a seal to collect menstrual fluids. Unlike a tampon, which absorbs the fluids, the menstrual cup simply collects while maintaining the natural moisture. Menstrual cups reduce the risk of TSS and hold more menstrual fluids than tampons. They can be used for approximately 10 years. Currently, there are two types of cups …
